Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Os Therapies Posts Wider Loss in Q2
Via The Motley Fool
Topics Intellectual Property
Tickers OSTX
Exposures Intellectual Property Product Safety
OS Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
Via Newsfile
Tickers OSTX
Exposures Product Safety
Kristin Edwards Releases Memoir on Resilience and Healing
Via Binary News Network
Topics Product Recall
Exposures Legal Product Safety
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark
Via Stocktwits
Tickers AVUS IWMW VNDA
Exposures Product Safety
This Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’
Via Stocktwits
Tickers IWMW TNXP UWM
Exposures Product Safety
Retail Chatter Surges Around Invivyd After Data Show Pemgarda Neutralizes XFG COVID-19 Variant
Via Stocktwits
Tickers IVVD
Exposures COVID-19 Product Safety
Advancements on Multiple Fronts in $3 Billion Suicidal Depression Market, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
Nyxoah (NYXH) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Intellectual Property Lawsuit
Tickers NYXH
Exposures Financial Intellectual Property Legal
Nyxoah Q2 Revenue Jumps 74 Percent
Via The Motley Fool
Tickers NYXH
Exposures Product Safety
$3 Billion Suicidal Depression Market Advancements on Multiple Fronts, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy
Via PRLog
Exposures Product Safety
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Via Benzinga
Tickers ATEC GMED JNJ MDT OFIX
Exposures Product Safety
Slate360 Provides Insights on Designing Impactful Healthcare Exhibits that are Compliance-Ready and Audience-Approved
Via Prodigy
Exposures Product Safety
Why Is Soligenix Stock Soaring On Monday?
Via Benzinga
Tickers SNGX
Exposures Product Safety
Why Did Catheter Precision Stock Soar 49% Today?
Via Stocktwits
Tickers VTAK
Exposures Product Safety
Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM,  ENTA)
Via News Direct
Topics Intellectual Property
Tickers MDCX
Exposures Intellectual Property Product Safety
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
Tickers ACI AMZN BTAI COST CVS HIT
Exposures Artificial Intelligence Product Safety
Market Movers: UnitedHealth, Intel, and Novo Nordisk Among Top Performers Reshaping the Financial Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Government
Tickers BRK-A BRK-B DAY DB INTC NVO
Exposures Artificial Intelligence Economy Political
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs and Strategic Investment
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Why Novo Nordisk Stock Popped Monday
Via The Motley Fool
Tickers LLY NVO
Exposures Product Safety
Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years
Via Benzinga
Tickers AXSM TNXP
Exposures Product Safety
Novo Nordisk Pops On A New Wegovy Approval, Dragging Hard On Madrigal Pharma
Via Investor's Business Daily
Tickers MDGL NVO
Exposures Product Safety
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Awarded FDA Orphan Drug Designation for Dusquetide in Behçet’s Disease
Via Investor Brand Network
Tickers SNGX
Exposures COVID-19 Product Safety
Shareholders of Capricor Therapeutics, Inc. Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Shareholders of Capricor Therapeutics, Inc. Should Contact Levi &amp; Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
FDA Approves New Fibromyalgia Drug, Tonix Shares Climb
Via Investor's Business Daily
Exposures Product Safety
Compounded Semaglutide Reviews 2025: Consumer Insights on Healthy Living and Wellness
Via AB Newswire
Topics Law Enforcement
Exposures Legal Product Safety
Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease
Via Benzinga
Tickers MDGL NVO
Exposures Product Safety
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.